SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Attention centers on TSMCs discussions about a potential role in Musks Texas Terafab project; traders debate whether its involvement would supplement Intels role or replace it, with no finalized deal established. The chatter also reflects bullish momentum and expectations that continued AI-chip demand will support TSMCs business.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Record quarterly results and a raised fiscal 2027 outlook, supported by AI data-center demand for Penguin Solutions infrastructure and memory businesses, are driving attention. Many traders are bullish on the beat-and-raise, while others debate whether the rally can hold amid profit-taking, resistance, and short-positioning concerns.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Elon Musks discussions with TSMC about its potential role in the Terafab project have raised concerns that Intel could lose some of the foundry opportunity or its exclusivity, weighing on sentiment. Intels CEO says the company will remain involved, and traders are divided over whether TSMC would supplement Intel or compete for its role.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs business update on production qualification, improving yields and planned capacity expansion is driving discussion, alongside frustration that it offered few concrete customer or shipment details. Bulls see progress toward commercialization, while skeptics question execution timelines and managements reliance on confidentiality restrictions.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistras rally is centered on the federal governments roughly $4.2 billion financing commitment for upgrades to its nuclear plants, with traders also tying the move to rising AI and data-center electricity demand. Many are bullish on the nuclear expansion and momentum, while others caution that the financing is conditional, adds debt, and may leave the shares vulnerable to profit-taking after a sharp move.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention for persistent small-cap underperformance as mega-cap technology leads broader indexes, with traders citing elevated Treasury yields and small companies rate sensitivity as headwinds. The debate is whether support near the long-term trend can spark a catch-up bounce or whether weak breadth and high borrowing costs will prolong the decline.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIMs raised full-year earnings guidance is driving attention, with traders reacting positively while speculating that managements outlook is conservative and stronger results could support larger dividends. Discussion also weighs the earnings outlook against uncertainty over Israeli approval of the Hapag-Lloyd deal.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as elevated long-term Treasury yields weigh on the fund, with traders pointing to inflation and oil risks, government debt and bond supply, and weakness in global bonds. Sentiment is broadly bearish, though some traders see oversold conditions and expect a rebound if yields ease.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Reports that SpaceX is seeking debt financing to buy Nvidia chips for its AI buildout dominate discussion. Traders are split over whether the spending can support future growth or adds debt and execution risk, with an upcoming share unlock adding to selling-pressure concerns.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist shares surged after Micron agreed to a five-year patent license and settlement that resolves the companies pending legal disputes. Traders largely view the recurring licensing revenue as a validation of Netlists memory patents, while debating whether the terms were favorable and speculating about a future SK hynix deal, Google developments, and a Nasdaq relisting.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS  VIALE-M Phase 3 $ABBV FAILED - AML FIRST REMISSION (CR1)  
BAT / Onureg + Venclexta / Aza+VEN --- has proven effective in achieving Remission / but not durable Survival - and has failed in trial after trial. 
 
• Oral Aza / Onureg is BAT for AML First Remission (CR1) MOS 24.7 Months.  
• Adding Venetoclax to Onureg, with 8 different dosing attempts - FAILED in the VIALE-M Phase 3 Trial. 
• Gps Phase 2 MOS in CR1 was not reached and &gt; 67.6 months - BAT 24.7 
• Gps Phase 2 MOS in CR2 was stat sig 21 months, in an OLDER, ALL MRD+ set of patients who rec&#39;d much less Gps than P3 GPS Patients.  
 
SLS is the Next $MRNA --- now you know.

Easy E

Juhana Tikkanen

Peggy Murphy

5,500% ROI this quarter

Wayne

upgrador

Karina F.

CMSP

$MRNA $SLS While we are seeing extended near miraculous ALL Pooled Survival in the SLS REGAL Phase 3  
- nearly 40% Survival at 3 years - in a transplant ineligible, Post Salvage AML Second Remission (CR2) Population with a expected MOS of just 6-8 months.  
BAT / Aza+VEN  / Onureg + Venclexta FAILED to Increase OS in 5 TRIALS: 
 
• VERONA Phase 3 $ABBV FAILED high risk MDS/AML Precursor 
• VIALE-M Phase 3 $ABBV FAILED - AML FIRST REMISSION (CR1) 
• VIALE-T Phase 3 $ABBV FAILED - AML Post Transplant Maintenance 
• Opti-AML Phase 2 MDACC Reduced Intensity  FAILED 
• Paradigm Phase 2 AML Front Line Modified Dosing again FAILED to Increase Survival.

StockTwits Web

Moderna Inc

SELLAS Life Sciences Group Inc

Abbvie Inc

 FAILED - AML FIRST REMISSION (CR1)  
BAT / Onureg + Venclexta / Aza+VEN --- has proven effective in achieving Remission / but not durable Survival - and has failed in trial after trial. 
 
• Oral Aza / Onureg is BAT for AML First Remission (CR1) MOS 24.7 Months.  
• Adding Venetoclax to Onureg, with 8 different dosing attempts - FAILED in the VIALE-M Phase 3 Trial. 
• Gps Phase 2 MOS in CR1 was not reached and > 67.6 months - BAT 24.7 
• Gps Phase 2 MOS in CR2 was stat sig 21 months, in an OLDER, ALL MRD+ set of patients who rec'd much less Gps than P3 GPS Patients.  
 
SLS is the Next 